Family Practice Advance Access published online on November 15, 2005
Family Practice, doi:10.1093/fampra/cmi094
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of General Practice/Family Medicine, University of Göttingen, 37073 Göttingen, Germany
* To whom correspondence should be addressed. Background. Little is known about doctors' decision-making processes in prescribing antidepressants and how this is handled. Objective. To describe and understand doctors' strategies in prescribing mood-modifying drugs, especially when confronted with challenging patients or situations. Methods. Face-to-face interviews were conducted with GPs in Göttingen and Hannover, two areas in the north of Germany. GPs were enrolled until a sufficient variation (saturation) had been reached (n = 19). Interviews were audiotaped and then transcribed verbatim. To analyse the GPs' concepts and strategies in prescribing antidepressants, the interviews were structured according to themes and recurrent items extracted by theoretical coding. Results. We identified four main strategies used by GPs in the pharmacological management of depressive patients: marketing additional beneficial drug effects, addressing the patients as experts, somatic attribution of the disease and referral to a specialist. Conclusions. To support their prescription, GPs use a variety of strategies to motivate both patients to take a certain drug and themselves to deal with difficult patients or situations in their management of depression.
Received March 2, 2005
Accepted October 17, 2005
Article
Doctors' strategies in prescribing drugs: the case of mood-modifying medicines
Anja Kapmeyer 1 *,
Christoph Meyer 1,
Michael M. Kochen 1,
and
Wolfgang Himmel 1
Anja Kapmeyer, E-mail: akapmey{at}gwdg.de
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?